Resonance Health LtdASX: RHT

Trading Halt

· Issued by Resonance Health Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Resonance Health Ltd has requested a trading halt for its securities pending an announcement regarding market-sensitive information. The halt will remain in effect until normal trading resumes or the announcement is released, whichever comes first. The announcement is expected to cover preliminary results from a clinical trial and a placement to investors.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Market Announcement 23 October 2026 Resonance Health Limited (ASX: RHT) – Trading Halt Trading in the securities of Resonance Health Limited (‘RHT’) will be halted at the request of RHT, pending the release of an announcement by RHT. Unless ASX decides otherwise, the securities will remain in...

Resonance Health Ltd on 6ix

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases